Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting, 66752-66754 [2013-26525]
Download as PDF
<![CDATA[
66752
Federal Register / Vol. 78, No. 215 / Wednesday, November 6, 2013 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
Under Appendix B of the NIH
Guidelines, most coronaviruses are
classified as RG2 viruses. Given the
severity of illness seen to date, MERSCoV will be added to the list of RG3
agents, as was done for SARS-CoV.
However, because little is currently
known about the source, reservoir, and
epidemiology of this virus, the RG
classification will be reassessed if new
data emerge relevant to the biosafety
risks associated with the agent. In
addition, while research with RG3
agents is often carried out at Biosafety
level 3 containment—with appropriate
enhancements depending upon the
nature of the agent, e.g., increased
respiratory precautions for agents that
are transmissible by the aerosol route—
the RG of an agent is not the only factor
that determines the containment level.
As stated in Section II–A of the NIH
Guidelines (Risk Assessment) ‘‘once the
risk group of an agent is identified, this
should be followed by a thorough
consideration of how the agent is to be
manipulated’’ and there may be
experiments for which a higher
containment level is warranted. Interim
Laboratory Biosafety Guidelines for
Handling and Processing Specimens
Associated with MERS-CoV are
available on the CDC Web site at the
following URL: https://www.cdc.gov/
coronavirus/mers/guidelines-labbiosafety.html.
Pseudomonas aeruginosa
Bacteria belonging to the genus
Pseudomonas are ubiquitous in the
environment. They are generally
considered to be opportunistic
pathogens, i.e., able to cause disease in
individuals who are
immunocompromised. According to the
CDC, serious pseudomonas infections
usually occur in hospitalized patients
and those who are
immunocompromised and these
infections can lead to severe illness and
death (https://www.cdc.gov/hai/
organisms/pseudomonas.html). Healthy
people can also become ill from
Pseudomonas aeruginosa, especially
after exposure to inadequately
disinfected water. Per the CDC, ‘‘Ear
infections, especially in children, and
more generalized skin rashes may occur
after exposure to inadequately
chlorinated hot tubs or swimming pools.
Eye infections have occasionally been
reported in persons using extendedwear contact lenses’’ (https://
www.cdc.gov/hai/organisms/
pseudomonas.html).
Because this bacterium generally
causes mild disease in healthy
individuals and there are antibiotics to
treat such disease, the OBA will add it
VerDate Mar<15>2010
17:25 Nov 05, 2013
Jkt 232001
to Appendix B as an RG2 bacterium.
This is consistent with other
assessments of the RG for this pathogen
by other biosafety guidances, including
the Canadian (https://www.phacaspc.gc.ca/lab-bio/res/psds-ftss/
pseudomonas-spp-eng.php) and the
European Community (https://
www.bacterio.net/hazard.html#group2)
guidances.
Appendix B–II–A. Risk Group 2
(RG2)—Bacterial Agents Including
Chlamydia.
The following addition will be made
to Appendix B–II–A. Risk Group 2
(RG2)—Bacterial Agents Including
Chlamydia:
Pseudomonas aeruginosa
The following addition will be made
to Appendix B–III–D Risk Group 3
(RG3)—Viruses and Prions:
Middle East Respiratory Syndrome
coronavirus (MERS-CoV)
Dated: October 30, 2013.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Enabling
Bioanalytical and Imaging Technologies
Study Section, October 10, 2013, 07:45
a.m. to October 11, 2013, 06:00 p.m.,
Sheraton Delfina Santa Monica Hotel,
530 West Pico Boulevard, Santa Monica,
CA 90405 which was published in the
Federal Register on September 12, 2013,
78 FR 177 Pg. 56239.
The meeting will be held at the
Renaissance Washington Dupont Circle
Hotel, 1143 New Hampshire Ave. NW.,
Washington, DC 20037. The meeting
will start December 17, 2013 at 9:30 a.m.
and end December 18, 2013 at 7:00 p.m.
The meeting is closed to the public.
Dated: October 31, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26529 Filed 11–5–13; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2013–26612 Filed 11–5–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Human Genome Research
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Human
Genome Research Institute Special
Emphasis Panel, October 15, 2013, 01:00
p.m. to October 15, 2013, 02:30 p.m.,
National Human Genome Research
Institute, 5635 Fishers Lane, Suite 3055,
Rockville, MD 20852 which was
published in the Federal Register on
September 16, 2013, 78 FR 26905.
The October 15, 2013 meeting has
been moved to December 5, 2013. The
meeting is closed to the public.
Dated: October 31, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26540 Filed 11–5–13; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Reproductive
Center’s.
Date: November 7–8, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
E:\FR\FM\06NON1.SGM
06NON1
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 215 / Wednesday, November 6, 2013 / Notices
Contact Person: Dennis E. Leszczynski,
Ph.D., Scientific Review Officer, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892, 301–435–2717, leszcyd@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Population Sciences
Subcommittee.
Date: November 7, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Carla T. Walls, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD
20892–7510, 301–435–6898, wallsc@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Pediatrics Subcommittee.
Date: November 12, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Rita Anand, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892,
301–496–1487, anandr@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; ZHD1 DSR–Z (55).
Date: November 12, 2013.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Peter Zelazowski, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892,
301–435–6902, peter.zelazowski@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
VerDate Mar<15>2010
17:25 Nov 05, 2013
Jkt 232001
Special Emphasis Panel; Preserving Male
Fertility After Cancer Therapy by Kyle E.
Orwig.
Date: November 14, 2013.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Officer, Division of
Scientific Review, National Institute of Child
Health and Human Development, 6100
Executive Boulevard, Rockville, MD 20892–
9304, (301) 435–6680, skandasa@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Obstetrics and Maternal-Fetal
Biology Subcommittee.
Date: November 20, 2013.
Time: 7:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Peter Zelazowski, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5b01, Bethesda, MD 20892, 301–
435–6902, peter.zelazowski@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; HIV-Infected
Children and Virologic Control.
Date: November 22, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Rita Anand, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892,
301–496–1487, anandr@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; ZHD1 DSR–Z (50).
Date: November 22, 2013.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Peter Zelazowski, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892,
301–435–6902, peter.zelazowski@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development Initial
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
66753
Review Group; Reproduction, Andrology,
and Gynecology Subcommittee.
Date: November 25, 2013.
Time: 3:30 p.m. to 7:00 p.m.
Date: November 26, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Dennis E. Leszczynski,
Ph.D., Scientific Review Officer, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd., Room 5b01, Bethesda, MD
20892, 301–435–2717, leszcyd@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel.
Date: November 7, 2013.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Cathy J. Wedeen, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, OD, Eunice Kennedy
Shriver National Institute of Child Health
and Human Development, NIH, 6100
Executive Blvd., Room 5B01–G, Bethesda,
MD 20892, 301–435–6878, wedeenc@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Developmental Biology
Subcommittee.
Date: November 13, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Date: November 14, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Date: November 18, 2013.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Cathy J. Wedeen, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, OD, Eunice Kennedy
Shriver National Institute of Child Health
And Human Development, NIH, 6100
Executive Blvd., Room 5B01–G, Bethesda,
MD 20892, 301–435–6878, wedeenc@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel.
Date: November 26, 2013.
Time: 12:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
E:\FR\FM\06NON1.SGM
06NON1
66754
Federal Register / Vol. 78, No. 215 / Wednesday, November 6, 2013 / Notices
Contact Person: Cathy J. Wedeen, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, OD, Eunice Kennedy
Shriver National Institute of Child Health
And Human Development, NIH, 6100
Executive Blvd., Room 5B01–G, Bethesda,
MD 20892, 301–435–6878, wedeenc@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Dated: October 31, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26525 Filed 11–5–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Special
Emphasis Panel: Behavioral Medicine,
Intervention and Outcomes.
Date: November 21, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Agenda: Loews L’Enfant Plaza Hotel, 480
L’Enfant Plaza SW., Washington, DC 20024–
2197.
Contact Person: Lee S Mann, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186,
MSC 7848, Bethesda, MD 20892, 301–435–
0677, mannl@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, RFA–DC–
13–002: Innovative and Novel Approaches
Toward Inner Ear Regenerative Therapies.
VerDate Mar<15>2010
17:25 Nov 05, 2013
Jkt 232001
Date: December 2, 2013.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Lynn E Luethke, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5166,
MSC 7844, Bethesda, MD 20892, (301) 806–
3323, luethkel@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Social
Psychology, Personality and Interpersonal
Processes Overflow.
Date: December 2, 2013.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Monica Basco, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3220,
MSC 7808, Bethesda, MD 20892, 301–496–
7010, bascoma@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Program
Project: Antibody Research Technology
Center.
Date: December 3–5, 2013.
Time: 5:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Nikko San Francisco, 222
Mason Street, San Francisco, CA 94102.
Contact Person: Scott Jakes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892, 301–495–
1506, jakesse@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, AREA:
Population Sciences and Epidemiology.
Date: December 6, 2013.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Karin F Helmers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3144,
MSC 7770, Bethesda, MD 20892, (301) 254–
9975, helmersk@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: October 31, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26530 Filed 11–5–13; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
October 18, 2013, 02:00 p.m. to October
18, 2013, 05:00 p.m., National Institutes
of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, which was
published in the Federal Register on
September 24, 2013, 78 FR 185 Pgs.
58547–58548.
The meeting will start December 18,
2013 at 2:00 p.m. and end December 18,
2013 at 5:00 p.m. The meeting location
remains the same. The meeting is closed
to the public.
Dated: October 31, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26528 Filed 11–5–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Cardiovascular Disease Model Resource
Related Research Project.
Date: December 4, 2013.
Time: 11:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
7182, 6701 Rockledge Drive Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Susan Wohler Sunnarborg,
Ph.D. Scientific Review Officer, Office of
Scientific Review/DERA National, Heart,
Lung, and Blood Institute, 6701 Rockledge
E:\FR\FM\06NON1.SGM
06NON1
]]>Agencies
[Federal Register Volume 78, Number 215 (Wednesday, November 6, 2013)]
[Notices]
[Pages 66752-66754]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26525]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Reproductive Center's.
Date: November 7-8, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
[[Page 66753]]
Contact Person: Dennis E. Leszczynski, Ph.D., Scientific Review
Officer, Division of Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01,
Bethesda, MD 20892, 301-435-2717, leszcyd@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Population Sciences Subcommittee.
Date: November 7, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Carla T. Walls, Ph.D., Scientific Review
Officer, Division of Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, NIH, 6100
Executive Boulevard, Room 5B01, Bethesda, MD 20892-7510, 301-435-
6898, wallsc@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Pediatrics Subcommittee.
Date: November 12, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Rita Anand, Ph.D., Scientific Review Officer,
Division of Scientific Review, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892, 301-496-1487,
anandr@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; ZHD1 DSR-Z (55).
Date: November 12, 2013.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Peter Zelazowski, Ph.D., Scientific Review
Officer, Division of Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD 20892, 301-435-6902,
peter.zelazowski@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Preserving Male Fertility After
Cancer Therapy by Kyle E. Orwig.
Date: November 14, 2013.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy, Ph.D., Scientific Review
Officer, Division of Scientific Review, National Institute of Child
Health and Human Development, 6100 Executive Boulevard, Rockville,
MD 20892-9304, (301) 435-6680, skandasa@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Obstetrics and Maternal-Fetal
Biology Subcommittee.
Date: November 20, 2013.
Time: 7:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Peter Zelazowski, Ph.D., Scientific Review
Officer, Division of Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, NIH, 6100
Executive Blvd., Room 5b01, Bethesda, MD 20892, 301-435-6902,
peter.zelazowski@nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; HIV-Infected Children and
Virologic Control.
Date: November 22, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Rita Anand, Ph.D., Scientific Review Officer,
Division of Scientific Review, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892, 301-496-1487,
anandr@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; ZHD1 DSR-Z (50).
Date: November 22, 2013.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Peter Zelazowski, Ph.D., Scientific Review
Officer, Division of Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD 20892, 301-435-6902,
peter.zelazowski@nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Reproduction, Andrology, and
Gynecology Subcommittee.
Date: November 25, 2013.
Time: 3:30 p.m. to 7:00 p.m.
Date: November 26, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Dennis E. Leszczynski, Ph.D., Scientific Review
Officer, Division of Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100 Executive Blvd., Room 5b01,
Bethesda, MD 20892, 301-435-2717, leszcyd@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel.
Date: November 7, 2013.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Cathy J. Wedeen, Ph.D., Scientific Review
Officer, Division of Scientific Review, OD, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01-G, Bethesda, MD 20892, 301-435-6878,
wedeenc@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Developmental Biology
Subcommittee.
Date: November 13, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Date: November 14, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Date: November 18, 2013.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Cathy J. Wedeen, Ph.D., Scientific Review
Officer, Division of Scientific Review, OD, Eunice Kennedy Shriver
National Institute of Child Health And Human Development, NIH, 6100
Executive Blvd., Room 5B01-G, Bethesda, MD 20892, 301-435-6878,
wedeenc@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel.
Date: November 26, 2013.
Time: 12:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
[[Page 66754]]
Contact Person: Cathy J. Wedeen, Ph.D., Scientific Review
Officer, Division of Scientific Review, OD, Eunice Kennedy Shriver
National Institute of Child Health And Human Development, NIH, 6100
Executive Blvd., Room 5B01-G, Bethesda, MD 20892, 301-435-6878,
wedeenc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Dated: October 31, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-26525 Filed 11-5-13; 8:45 am]
BILLING CODE 4140-01-P
